Heterogeneity can significantly impact treatment outcomes. Genetic and molecular variations among tumors can lead to differential responses to the same therapy. Understanding the specific characteristics of a patient's tumor can help tailor treatment plans, minimize adverse effects, and improve overall efficacy. However, this requires comprehensive profiling of the tumor and continuous monitoring.
